NVAC Resolution: Resources to Support Vaccine Safety
September 29, 1998
WHEREAS, the Food and Drug Administration’s Center for Biologic Evaluation and Research (CBER) budget is decreasing at a time of increasing complexity of the technology in vaccine development; and
WHEREAS, the decrease in personnel and research resulting from these budget reductions threatens the availability of safe and effective vaccines in the United States
Then, be it resolved that the NVAC recommends that the Secretary for Health and Human Services and the National Vaccine Program Office explore means to ensure that CBER has the resources necessary to continue their mission of assuring that safe and effective vaccines are available and that the health of the public is not jeopardized.